Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
NCT05748730 · View on ClinicalTrials.gov ↗
Study Summary
This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cybervictimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicidal-related events by 50%, and the effects will be mediated by increases in referrals, treatment engagement, and safety planning. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.
Conditions Studied
Interventions
- BEHAVIORAL iCHART
- BEHAVIORAL Treatment As Usual
Study Locations (13)
Pennsylvania
- Conemaugh Memorial Medical Center-Family Medicine — Johnstown
- CHOP Primary Care, CHOP Campus — Philadelphia
- Roxborough — Philadelphia
- CHOP Primary Care, Cobbs Creek — Philadelphia
- Karabots — Philadelphia
- Children's Community Pediatrics (CCP) of Children's Hospital of Pittsburgh UPMC — Pittsburgh
- UPMC Center for Adolescent and Young Adult Health — Pittsburgh
- UPMC Family Medicine — Pittsburgh
- Kids Plus Pediatrics (KPP) — Pittsburgh
- Berks Community Health Center — Reading
- Springfield — Springfield
- CHOP Primary Care, West Chester — West Chester
New Jersey
- Gibbsboro — Gibbsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2023-01-26 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05748730
The ClinicalTrials.gov registry entry for NCT05748730 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,082 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Adolescent Behavior appearing as the primary indexed condition, and to 2 interventions — of which iCHART is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05748730 reports 13 study locations spanning 2 distinct geographic areas — top geographies include Pennsylvania, New Jersey. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05748730 about?
NCT05748730 is a clinical study titled "Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention". This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, ...
What is the current status of trial NCT05748730?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-01-26. Estimated completion is 2027-04-30.
What conditions does trial NCT05748730 study?
This clinical trial studies the following conditions: Adolescent Behavior, Suicide and Depression. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05748730?
The interventions under investigation include: iCHART (BEHAVIORAL), Treatment As Usual (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05748730?
This trial is sponsored by University of Pittsburgh, which has 1,082 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05748730 being conducted?
This trial has 13 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.